
Kuros Biosciences Investor Relations Material
Latest events

H1 2025
Kuros Biosciences
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Kuros Biosciences AG
Access all reports
Kuros Biosciences AG, operating under the ticker KURN, is a biotechnology company dedicated to discovering, developing, and delivering innovative fusion technologies for bone grafting. Founded as a spin-off from the Swiss Federal Institute of Technology in Zurich in 2000, Kuros Biosciences has established a significant presence in the field of tissue repair and regeneration. The company's flagship product line, MagnetOs, is designed for applications in spinal fusion, trauma, fracture repair, and as surgical sealants. The company is headquartered in Zurich, Switzerland, and its shares are listed on SIX.
Key slides for Kuros Biosciences AG


H2 2024
Kuros Biosciences AG


CMD 2025
Kuros Biosciences AG
Latest articles
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
Ticker symbol
KURN
Country
🇨🇭 Switzerland